Background: In trauma, most hemorrhagic deaths occur within the first 6 hours. This study examined the effect on survival of high ratios of fresh frozen plasma (FFP) and platelets (PLTs) to packed red blood cells (PRBCs) in the first 6 hours.
Methods: Records of 466 massive transfusion trauma patients (>or=10 U of PRBCs in 24 hours) at 16 level 1 trauma centers were reviewed. Transfusion ratios in the first 6 hours were correlated with outcome.
Results: All groups had similar baseline characteristics. Higher 6-hour ratios of FFP:PRBCs and PLTs:PRBCs lead to improved 6-hour mortality (from 37.3 [in the lowest ratio group] to 15.7 [in the middle ratio group] to 2.0% [in the highest ratio group] and 22.8% to 19.0% to 3.2%, respectively) and in-hospital mortality (from 54.9 to 41.1 to 25.5% and 43.7% to 46.8% to 27.4%, respectively). Initial higher ratios of FFP:PRBCs and PLTs:PRBCs decreased overall PRBC transfusion.
Conclusions: The early administration of high ratios of FFP and platelets improves survival and decreases overall PRBC need in massively transfused patients. The largest difference in mortality occurs during the first 6 hours after admission, suggesting that the early administration of FFP and platelets is critical.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.amjsurg.2008.12.014 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Association of febrile neutropenia episodes and blood product transfusions in children with acute leukemia.
Transfus Apher Sci
December 2024
Department of Pediatric Hematology, Dokuz Eylül University, İzmir, Turkey. Electronic address:
Objective: Transfusion is vital supportive therapy in leukemias, but has significant potential febrile complications. In this study, we aimed to reveal the possible effects of blood product transfusions on febrile neutropenia episodes (FNEs) in children with acute leukemia.
Methods: We obtained the relevant clinical and laboratory data from the medical records.
Outcomes Associated with a Patient Blood Management Program in Major Obstetric Hemorrhage: A Retrospective Cohort Study.
Anesth Analg
November 2024
Medical School, Division of Surgery, The University of Western Australia, Perth, Western Australia, Australia.
Background: Obstetric patient blood management (PBM) strategies were used at Corniche Hospital in 2018, initially focusing on minimizing bleeding, with other clinical strategies implemented incrementally. This study assesses program outcomes in patients with major obstetric hemorrhage of 2000 mL or greater.
Methods: A retrospective study of 353 women admitted to The Corniche Hospital between 2018 and 2023 who experienced major obstetric hemorrhage of 2000 mL or greater.
A child with factor V deficiency with a novel F5 gene mutation misdiagnosed as a left iliac fossa abscess: A case report.
Medicine (Baltimore)
November 2024
Department of Pediatrics, West China Second Hospital, Sichuan University, Chengdu, People's Republic of China.
Rationale: Congenital factor V deficiency is classified as a rare bleeding disorder that is expressed in an autosomal recessive manner and generally occurs in 1 in a million people. This disorder is accompanied by a variety of clinical manifestations, which can easily lead to misdiagnosis. This is the first report to identify the factor V gene variant c.
View Article and Find Full Text PDFAdherence to balanced transfusion among severely injured patients: A post hoc analysis of the RESTRIC trial.
Acute Med Surg
November 2024
Article Synopsis
- A study aimed to evaluate the adherence to a balanced transfusion strategy in severely injured patients in Japan, which is believed to lower mortality rates during resuscitation.
- The researchers analyzed data from the RESTRIC trial, categorizing patients into two massive transfusion groups based on the volume of red blood cell (RBC) transfusions they received.
- Results showed that while the ratio of fresh frozen plasma (FFP) to RBC transfusions was consistently balanced, the platelet concentrate (PC) to RBC ratio was not fully balanced, especially in the early phases of treatment.
The History of Rare Bleeding Disorders.
Semin Thromb Hemost
November 2024
Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Deficiencies in coagulation factors I (FI), FII, FV, combined FV and FVIII (CF5F8) and vitamin K-dependent coagulation factors FVII, FX, FXI, and FXIII have been referred to as rare bleeding disorders (RBDs), rare coagulation factor deficiencies (RCFDs), or recessively inherited coagulation disorders. Fibrinogen was most likely the first member of this group to be identified, with reports of its discovery spanning from 1859 to 1966. If not, then the first coagulation factor to be identified was prothrombin in 1894, and the last coagulation factor to be found was FX in 1956, about 60 years later.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!